We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. The Administrator of personal data is STOCKTRADEIQ sp. z o.o., with its registered office in Poznan (61-625), at the following address: Czarna Rola 30 Street. Cookies policy here. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

  • Cookie
    cookieyes-consent
  • Duration
    1 year
  • Description
    CookieYes sets this cookie to remember users' consent preferences so that their preferences are respected on their subsequent visits to this site. It does not collect or store any personal information of the site visitors.
  • Cookie
    x-ms-cpim-csrf
  • Duration
    session
  • Description

    Inter-site request forgery token used to protect crSF. For more information, read the section Token falsification of requests between sites.

  • Cookie
    x-ms-cpim-sso:stocktradeiqauth.onmicrosoft.com_0
  • Duration
    session
  • Description

    Used to support single sign-on sessions. This cookie is set as persistent when the Keep me logged in option is enabled.

  • Cookie
    server-telemetry-{id}
  • Duration
    persistent
  • Description

    A value used by Microsoft for authorisation and authentication.

  • Cookie
    google_auto_fc_cmp_setting
  • Duration
    persistent
  • Description


    Stores the state of the User cookie for the current domain.

     

  • Cookie
    {id}-https://stocktradeiqauth.onmicrosoft.com/{id}
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    msal{id}.active-account
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-refreshtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-idtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    Microsoft Clarity
  • Duration
    1 year
  • Description

    Microsoft Clarity

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

  • Cookie
    isLightMode
  • Duration
    1 year
  • Description

    Defines the UI theme

  • Cookie
    userCultureData
  • Duration
    persistent
  • Description

     Stores information about the user's machine culture.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

  • Cookie
    _ga
  • Duration
    1 year 1 month 4 days
  • Description
    The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
  • Cookie
    _ga_*
  • Duration
    1 year 1 month 4 days
  • Description
    Google Analytics sets this cookie to store and count page views.
  • Cookie
    hotjar
  • Duration
    1 year 1 month 4 days
  • Description

    Analyzing users' behaviour in the website

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

  • Cookie
    __gpi
  • Duration
    1 year 24 days
  • Description
    Google Ads Service uses this cookie to collect information about from multiple websites for retargeting ads.
  • Cookie
    __gads
  • Duration
    1 year 24 days
  • Description

    The file, set by Google, is stored in the DoubleClick domain and tracks the number of times users view an ad, measures the success of the campaign and calculates its revenue. This cookie can only be read from the domain where it is set and does not track any data when browsing other sites.

  • Cookie
    goog:cached:topics
  • Duration
    persistent
  • Description

    It is used to record which adverts have been displayed to the User.

  • Cookie
    IDE
  • Duration
    year
  • Description

    Used by Google DoubleClick to record and report on the Website User's actions after viewing or clicking on an advertiser's ads in order to measure the effectiveness of the ad and present the User with targeted advertising.

  • Cookie
    google_experiment_mod44
  • Duration
    persistent
  • Description

    Used by Google Ad to experiment with the effectiveness of ads on websites using their services.

Powered by Cookieyes logo

    Get Diamond plan for FREE

    logo

    Orion Biotech Opportunities Corp. (ORIAU)

    Price:

    9.00 USD

    ( - 0 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    ORIAU
    Name
    Orion Biotech Opportunities Corp.
    Industry
    Shell Companies
    Sector
    Financial Services
    Price
    9.000
    Market Cap
    0
    Enterprise value
    200.734M
    Currency
    USD
    Ceo
    Zuie-Chin Huang
    Full Time Employees
    Website
    orionbiotechopportunities.com
    Ipo Date
    2021-05-11
    City
    New York City
    Address
    645 Fifth Avenue

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Agriculture & Natural Solutions Acquisition Corporation

    VALUE SCORE:

    6

    Symbol
    ANSCW
    Market Cap
    469.812M
    Industry
    Shell Companies
    Sector
    Financial Services

    2nd position

    Drugs Made In America Acquisition Corp. Ordinary Shares

    VALUE SCORE:

    11

    Symbol
    DMAA
    Market Cap
    344.556M
    Industry
    Shell Companies
    Sector
    Financial Services

    The best

    Drugs Made In America Acquisition Corp. Rights

    VALUE SCORE:

    11

    Symbol
    DMAAR
    Market Cap
    344.556M
    Industry
    Shell Companies
    Sector
    Financial Services
    FUNDAMENTALS
    P/E
    11.112
    P/S
    0
    P/B
    1.049
    Debt/Equity
    0
    EV/FCF
    0.705
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0
    Earnings yield
    0.090
    Debt/assets
    0
    FUNDAMENTALS
    Net debt/ebidta
    0.025
    Interest coverage
    0
    Research And Developement To Revenue
    0
    Intangile to total assets
    0
    Capex to operating cash flow
    0
    Capex to revenue
    0
    Capex to depreciation
    0
    Return on tangible assets
    0.091
    Debt to market cap
    Piotroski Score
    2.000
    FUNDAMENTALS
    PEG
    0.111
    P/CF
    -543.056
    P/FCF
    0
    RoA %
    9.055
    RoIC %
    -0.931
    Gross Profit Margin %
    0
    Quick Ratio
    6.499
    Current Ratio
    6.499
    Net Profit Margin %
    0
    Net-Net
    -0.403
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.019
    Revenue per share
    0
    Net income per share
    0.921
    Operating cash flow per share
    -0.019
    Free cash flow per share
    -0.019
    Cash per share
    0.013
    Book value per share
    9.750
    Tangible book value per share
    9.750
    Shareholders equity per share
    9.750
    Interest debt per share
    0
    TECHNICAL
    52 weeks high
    10.635
    52 weeks low
    9.000
    Current trading session High
    9.000
    Current trading session Low
    9.000
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    DESCRIPTION

    Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.

    NEWS
    https://images.financialmodelingprep.com/news/orion-biotech-opportunities-corp-announces-the-separate-trading-of-20210701.jpg
    Orion Biotech Opportunities Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing July 2, 2021

    prnewswire.com

    2021-07-01 20:30:00

    NEW  YORK, July 1, 2021 /PRNewswire/ -- Orion Biotech Opportunities Corp. (Nasdaq: ORIAU) (the "Company" or "us") announced that, commencing July 2, 2021, holders of the units sold in the Company's initial public offering of 20,000,000 units, completed on May 17, 2021, may elect to separately trade the Class A ordinary shares and warrants included in the units. Those units that are not separated at the election of the holder will continue to trade on the Nasdaq Stock Market LLC ("Nasdaq") under the symbol "ORIAU," and the Class A ordinary shares and warrants that are separated will trade on the Nasdaq under the symbols "ORIA" and "ORIAW," respectively.

    https://images.financialmodelingprep.com/news/orion-biotech-opportunities-corp-announces-pricing-of-200000000-initial-20210512.jpg
    Orion Biotech Opportunities Corp. Announces Pricing of $200,000,000 Initial Public Offering

    prnewswire.com

    2021-05-12 21:35:00

    NEW YORK, May 12, 2021 /PRNewswire/ -- Orion Biotech Opportunities Corp. (the "Company") today announced the pricing of its initial public offering ("IPO") of 20,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market LLC (the "Nasdaq") and trade under the symbol "ORIAU" beginning May 13, 2021.